IMVT — Immunovant Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapSucker Stock

Annual balance sheet for Immunovant, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	400	494	377	635	714
Net Total Accounts Receivable
Net Total Receivables	0.548	12.9	0.885	5.5	2.51
Prepaid Expenses
Total Current Assets	409	513	404	666	768
Net Property, Plant And Equipment	3.48	2.63	1.5	0.595	0.942
Other Long Term Assets
Total Assets	412	516	406	666	776
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	18.8	44.5	43.3	48.6	68.8
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	21	45.7	43.3	48.6	68.8
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	391	470	362	618	707
Total Liabilities & Shareholders' Equity	412	516	406	666	776
Total Common Shares Outstanding